Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-27 @ 11:48 PM
Study NCT ID:
NCT01097460
Status:
COMPLETED
Last Update Posted:
2015-01-07
First Post:
2010-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Sponsor:
Merrimack Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-04
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-30
First Submit QC Date:
None
Study First Post Date:
2010-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-01
Results First Submit QC Date:
None
Results First Post Date:
2014-12-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-12-18
Last Update Post Date:
2015-01-07
Last Update Post Date Type:
ESTIMATED